XML 67 R60.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Earnings Per Share [Abstract]        
Net loss attributable to Adaptive Biotechnologies Corporation $ (46,222) $ (47,810) $ (93,729) $ (105,509)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 147,414,095 144,397,693 146,600,811 143,956,867
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.31) $ (0.33) $ (0.64) $ (0.73)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 147,414,095 144,397,693 146,600,811 143,956,867
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.31) $ (0.33) $ (0.64) $ (0.73)